Atlas Trials

An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus

Clinical trial NCT02433314 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT02433314
Sponsor
Supernus Pharmaceuticals, Inc.
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Super-Refractory Status Epilepticus

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.